subscribeSubscribe
Saba İlaç`s Generic Furosemide Receives Approvals in the U.S

Saba İlaç`s Generic Furosemide Receives Approvals in the U.S
FDA
02 Apr 2024
Share Share
Avenacy Announces Launch of Furosemide for Injection in the U.S. Market

Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
BUSINESSWIRE
20 Mar 2024
Share Share
Intas Pharmaceuticals Limited on FDA Import Alert List

Intas Pharmaceuticals Limited on FDA Import Alert List
FDA
06 Jun 2023
Share Share
Enforcement Report - Week of January 18, 2023

Enforcement Report - Week of January 18, 2023
FDA
18 Jan 2023
Share Share
Mankind`s Generic Furosemide Receives Approval in the U.S.

Mankind`s Generic Furosemide Receives Approval in the U.S.
FDA
16 Dec 2022
Share Share
Salix Will Present Rifaximin Data at AASLD`s The Liver Meeting(R) 2022

Salix Will Present Rifaximin Data at AASLD`s The Liver Meeting(R) 2022
ACCESSWIRE
04 Nov 2022
Share Share
Graviti`s Generic Furosemide Receives Approval in the U.S.

Graviti`s Generic Furosemide Receives Approval in the U.S.
FDA
17 Oct 2022
Share Share
FDA signs off on scPharmaceutical’s on-body infusor for HF

FDA signs off on scPharmaceutical’s on-body infusor for HF
Kevin Dunleavy FIERCEPHARMA
11 Oct 2022
Share Share
scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide)

scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide)
GLOBENEWSWIRE
10 Oct 2022
Share Share
scPharmaceuticals to Host FUROSCIX 80mg/10mL for Subcutaneous Administration

scPharmaceuticals to Host FUROSCIX 80mg/10mL for Subcutaneous Administration
GLOBENEWSWIRE
30 Jun 2022
Share Share